Literature DB >> 11177315

The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse.

D R Harris1, R Gonin, H J Alter, E C Wright, Z J Buskell, F B Hollinger, L B Seeff.   

Abstract

BACKGROUND: Although concomitant alcoholism is widely believed to enhance liver disease progression in persons with hepatitis C virus (HCV) infection, this relationship has not been well quantified.
OBJECTIVE: To quantify the relationship of transfusion-associated HCV infection and history of heavy alcohol abuse to development of cirrhosis.
DESIGN: Retrospective cohort study.
SETTING: Liver clinics in university and government hospitals. PATIENTS: Extended follow-up of 1030 patients in prospective investigations of transfusion-associated viral hepatitis conducted in the United States between 1968 and 1980. MEASUREMENTS: Development of cirrhosis and history of heavy alcohol abuse were determined from review of interviews with patients or their proxies, medical records, death certificates, and autopsy and biopsy reports. Logistic regression was used to estimate the risk for cirrhosis associated with transfusion-associated HCV infection and history of heavy alcohol abuse.
RESULTS: The absolute risk for cirrhosis was 17% among patients with transfusion-associated HCV; 3.2% among patients with transfusion-associated non-A, non-B, non-C hepatitis; and 2.8% among controls. Patients with transfusion-associated HCV were more likely than controls to develop cirrhosis (odds ratio, 7.8 [95% CI, 4.0 to 15.1]). A history of heavy alcohol abuse was associated with a fourfold increased risk for cirrhosis. Hepatitis C virus infection plus a history of heavy alcohol abuse led to a substantial increase in risk for cirrhosis (odds ratio, 31.1 [CI, 11.4 to 84.5]) compared with controls without such a history.
CONCLUSIONS: Heavy alcohol abuse greatly exacerbates the risk for cirrhosis among patients with HCV infection. This finding emphasizes the need to counsel such patients about their drinking habits.

Entities:  

Mesh:

Year:  2001        PMID: 11177315     DOI: 10.7326/0003-4819-134-2-200101160-00012

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  39 in total

1.  Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection.

Authors:  Fasiha Kanwal; Tuyen Hoang; Jennifer R Kramer; Steven M Asch; Matthew Bidwell Goetz; Angelique Zeringue; Peter Richardson; Hashem B El-Serag
Journal:  Gastroenterology       Date:  2010-12-22       Impact factor: 22.682

2.  Clinical course of infection with hepatitis C.

Authors:  Sandro Vento; Valerio Nobili; Francesca Cainelli
Journal:  BMJ       Date:  2006-02-18

3.  Enhanced chronic hepatitis C surveillance in New York City, April 2009-January 2011.

Authors:  Kate Drezner; Katherine Bornschlegel; Emily McGibbon; Sharon Balter
Journal:  Public Health Rep       Date:  2013 Nov-Dec       Impact factor: 2.792

Review 4.  Alcohol use and hepatitis C.

Authors:  Marion G Peters; Norah A Terrault
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

5.  Chronic alcohol-induced liver disease inhibits dendritic cell function.

Authors:  Dechun Feng; Ahmet Eken; Vivian Ortiz; Jack R Wands
Journal:  Liver Int       Date:  2011-03-21       Impact factor: 5.828

Review 6.  Treatment decisions and contemporary versus pending treatments for hepatitis C.

Authors:  Paul M Trembling; Sudeep Tanwar; William M Rosenberg; Geoffrey M Dusheiko
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-10       Impact factor: 46.802

7.  Barriers to treatment of hepatitis C in HIV/HCV-coinfected adults with alcohol problems.

Authors:  David Nunes; Richard Saitz; Howard Libman; Debbie M Cheng; John Vidaver; Jeffrey H Samet
Journal:  Alcohol Clin Exp Res       Date:  2006-09       Impact factor: 3.455

Review 8.  KASL clinical practice guidelines: management of hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

Review 9.  Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.

Authors:  Amber Arain; Geert Robaeys
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

10.  Combined effects of alcohol and hepatitis C: a secondary analysis of alcohol use biomarkers and high-risk behaviors from two medication trials for alcohol dependence.

Authors:  Jennifer G Plebani; Carlos F Tirado; Helen M Pettinati; Kyle M Kampman; Joseph R Volpicelli; David W Oslin
Journal:  Addict Behav       Date:  2009-09-10       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.